Finance

Lists
PTGX:NASDAQ
Protagonist Therapeutics Inc
$ 145.72
-2.07%
(-3.08) 1D
$ 145.00
-0.49% (-0.72)
After hours
Closed: 9-р сарын 4, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTGX...
Open
$ 146.47
High
$ 147.99
Low
$ 144.01
Mkt. cap
9.43 тэрбум
Avg. vol.
484.95 мян
Volume
501.30 мян
P/E ratio
140.50
52-wk high
$ 160.81
52-wk low
$ 54.50
EPS
$ 1.04
Beta
1.80
Shares outstanding
64.71 сая
No. of employees
141
Open
$ 146.47
High
$ 147.99
Low
$ 144.01
Mkt. cap
9.43 тэрбум
Avg. vol.
484.95 мян
Volume
501.30 мян
P/E ratio
140.50
52-wk high
$ 160.81
52-wk low
$ 54.50
EPS
$ 1.04
Beta
1.80
Shares outstanding
64.71 сая
No. of employees
141
News stories
From web sources and news partners
About Protagonist Therapeutics Inc
CEO-
Employees141
Founded2006
HeadquartersNewark, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Websiteprotagonist-inc.com
Analyst ratings
Based on 12 analysts giving stock ratings to PTGX in the past 3 months
Strong buy
Buy
12
Hold
0
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for PTGX in the last 3 months.
Highest
Current $ 145.72
$ 186.00 (+27.64%)
Average
$ 167.00 (+14.60%)
Lowest
$ 121.00 (-16.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Richard Law CFA
Goldman Sachs
Buy
Maintained
$ 186.00
+27.6%
08/31/2026
Brian Cheng
J.P. Morgan
Buy
Reiterated
$ 149.00
+2.3%
08/31/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
09/01/2026
Etzer Darout
Barclays
Buy
Maintained
$ 180.00
+23.5%
08/31/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
$ 173.00
+18.7%
08/31/2026
Geoff Meacham
Citi
Buy
Maintained
$ 182.00
+24.9%
09/01/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$ 170.00
+16.7%
08/31/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$ 170.00
+16.7%
09/01/2026
Evan Seigerman
BMO Capital
Buy
Maintained
$ 178.00
+22.2%
08/30/2026
Yun Zhong
Wedbush
Buy
Maintained
$ 173.00
+18.7%
08/31/2026
Tara Bancroft
TD Cowen
Buy
Maintained
$ 155.00
+6.4%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
$ 121.00
-17%
07/16/2026
Unknown Analyst
Leerink Partners
Buy
Maintained
$ 110.00
-24.5%
03/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
4.71 сая
7.44 сая
56.37 сая
213.48 сая
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
40.00 сая
46.36 сая
46.74 сая
42.06 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.13 сая
11.43 сая
13.28 сая
12.65 сая
Operating expense
51.13 сая
57.79 сая
60.02 сая
54.71 сая
Total operating expenses
51.13 сая
57.79 сая
60.02 сая
54.71 сая
Operating income
-46.42 сая
-50.36 сая
-3.65 сая
158.77 сая
Other non operating income
-
27.00 мян
53.00 мян
-81.00 мян
EBT including unusual items
-39.34 сая
-43.72 сая
2.28 сая
165.11 сая
EBT excluding unusual items
-39.34 сая
-43.72 сая
2.28 сая
165.11 сая
Income tax expense
-
666.00 мян
-1.50 сая
2.26 сая
Effective tax rate
-
-1.52%
-65.85%
1.37%
Other operating expenses
-
-
-
-
Net income
-39.34 сая
-44.38 сая
3.78 сая
162.85 сая
Net profit margin
-834.87%
-596.80%
6.71%
76.28%
Earnings per share
-0.62
-0.69
0.05
2.29
Interest and investment income
7.05 сая
6.76 сая
5.88 сая
6.43 сая
Interest expense
-
-
-
-
Net interest expenses
7.05 сая
6.76 сая
5.88 сая
6.43 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-46.06 сая
-49.98 сая
-3.24 сая
159.16 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс